DESCRIBE <http://purl.uniprot.org/SHA-384/A8ABD43D500BB63A88C068F04A81422774D0DCC70C5C2AF5A6DF4389D6BE530884AA5D5E4D4CB0E46E1A0469F03D1DCD>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/A8ABD43D500BB63A88C068F04A81422774D0DCC70C5C2AF5A6DF4389D6BE530884AA5D5E4D4CB0E46E1A0469F03D1DCD	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A8ABD43D500BB63A88C068F04A81422774D0DCC70C5C2AF5A6DF4389D6BE530884AA5D5E4D4CB0E46E1A0469F03D1DCD	http://www.w3.org/2000/01/rdf-schema#comment	"our data identify EBP50 as a previously unidentified regulator of Nox1 and support that it promotes Nox1 activity by binding p47(phox) This interaction is pivotal for agonist-induced smooth muscle ROS hypertrophy and vasoconstriction and has implications for ROS-mediated physiological and pathophysiological processes."xsd:string
http://purl.uniprot.org/uniprot/#_B5A8958FD5F70916FB5112C77585FADB9CE4A501AFE9A96D644795BAADCC875DB4598CDF35480BDBAFC072621D1391B3	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/A8ABD43D500BB63A88C068F04A81422774D0DCC70C5C2AF5A6DF4389D6BE530884AA5D5E4D4CB0E46E1A0469F03D1DCD
http://purl.uniprot.org/uniprot/Q3TG37	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/A8ABD43D500BB63A88C068F04A81422774D0DCC70C5C2AF5A6DF4389D6BE530884AA5D5E4D4CB0E46E1A0469F03D1DCD
http://purl.uniprot.org/uniprot/#_Q3TG37-mappedCitation-27540115	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/A8ABD43D500BB63A88C068F04A81422774D0DCC70C5C2AF5A6DF4389D6BE530884AA5D5E4D4CB0E46E1A0469F03D1DCD